Literature DB >> 131801

Thymidylate nucleotide supply for mitochondrial DNA synthesis in mouse L-cells. Effect of 5-fluorodeoxyuridine and methotrexate in thymidine kinase plus and thymidine kinase minus cells.

D Bogenhagen, D A Clayton.   

Abstract

The effects of 5-fluorodeoxyuridine and methotrexate on [3H]thymidine and 32P labeling of mtDNA were studied in two lines of mouse L-cells. LMTK- cells, which lack the major cellular thymidine kinase (EC 2.7.1.21) but contain a genetically distinct mitochondrial enzyme, were compared to LA9 cells, which contain both thymidine kinase activities. LMTK- cells were resistant to 5-flurodeoxyuridine by a factor of 200 in comparison to LA9 cells. In both cells lines appropriate drug treatment increased utilization of exogenous thymidine for mtDNA synthesis. The maximum enhancement was 10- to 12-fold for LA9 cells and approximately 20-fold for LMTK- cells when treated with 10 muM methotrexate. The rates of mtDNA and nuclear DNA synthesis during drug treatment were analyzed with 32P labeling and 5-bromo-2'-deoxyuridine density labeling experiments. Synthesis of both mtDNA and nuclear DNA were strongly inhibited by drug treatment of either LA9 or LMTK- cells in the absence of exogenous thymidine. The rate of mtDNA synthesis substantially exceeded that of nuclear DNA in LA9 cells treated with 4 muM 5-fluorodeoxyuridine and less than 5 muM thymidine. Both synthetic rates approached those of untreated LA9 control cultures if 20 muM thymidine was present during 5-fluorodeoxyuridine treatment. In contrast, in LMTK- cells treated with 10 muM methotrexate and 20 muM thymidine, mtDNA synthesis continued at 50 to 60% of the control rate for at least 10 hours while nuclear DNA synthesis was 96% inhibited. Synthesis of mtDNA mass-labeled in both strands with 5-bromouracil occurred when LMTK- cells were incubated for 30 hours with 10 muM methotrexate and 20 muM 5-bromodeoxyuridine. These results indicate that mtDNA synthesis is resistant to a limitation of the thymidine triphosphate supply and is not strictly dependent upon concomitant nuclear DNA synthesis in these cells.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 131801

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  15 in total

1.  Cloning and characterization of full-length mouse thymidine kinase 2: the N-terminal sequence directs import of the precursor protein into mitochondria.

Authors:  L Wang; S Eriksson
Journal:  Biochem J       Date:  2000-10-15       Impact factor: 3.857

Review 2.  CoQ(10) deficiencies and MNGIE: two treatable mitochondrial disorders.

Authors:  Michio Hirano; Caterina Garone; Catarina M Quinzii
Journal:  Biochim Biophys Acta       Date:  2012-01-18

3.  Rearrangements of human mitochondrial DNA (mtDNA): new insights into the regulation of mtDNA copy number and gene expression.

Authors:  Y Tang; E A Schon; E Wilichowski; M E Vazquez-Memije; E Davidson; M P King
Journal:  Mol Biol Cell       Date:  2000-04       Impact factor: 4.138

4.  DNA synthesis in purified maize mitochondria.

Authors:  P Bedinger; V Walbot
Journal:  Curr Genet       Date:  1986       Impact factor: 3.886

5.  Valproyl-CoA inhibits the activity of ATP- and GTP-dependent succinate:CoA ligases.

Authors:  Paula B M Luís; Jos Ruiter; Lodewijk IJlst; Isabel Tavares de Almeida; Marinus Duran; Ronald J A Wanders; Margarida F B Silva
Journal:  J Inherit Metab Dis       Date:  2013-10-24       Impact factor: 4.982

6.  Differential regulation of full-length genome and a single-stranded 7S DNA along the cell cycle in human mitochondria.

Authors:  Anita Antes; Inger Tappin; Stella Chung; Robert Lim; Bin Lu; Andrew M Parrott; Helene Z Hill; Carolyn K Suzuki; Chee-Gun Lee
Journal:  Nucleic Acids Res       Date:  2010-06-08       Impact factor: 16.971

7.  Multienzyme complex for metabolic channeling in mammalian DNA replication.

Authors:  G Prem veer Reddy; A B Pardee
Journal:  Proc Natl Acad Sci U S A       Date:  1980-06       Impact factor: 11.205

8.  Antiviral activity of arabinosylthymine in herpesviral replication: mechanism of action in vivo and in vitro.

Authors:  J F Aswell; G P Allen; A T Jamieson; D E Campbell; G A Gentry
Journal:  Antimicrob Agents Chemother       Date:  1977-08       Impact factor: 5.191

9.  Site-specific somatic mitochondrial DNA point mutations in patients with thymidine phosphorylase deficiency.

Authors:  Yutaka Nishigaki; Ramon Martí; William C Copeland; Michio Hirano
Journal:  J Clin Invest       Date:  2003-06       Impact factor: 14.808

10.  Effects of 5'-fluoro-2-deoxyuridine on mitochondrial biology in Caenorhabditis elegans.

Authors:  J P Rooney; A L Luz; C P González-Hunt; R Bodhicharla; I T Ryde; C Anbalagan; J N Meyer
Journal:  Exp Gerontol       Date:  2014-04-03       Impact factor: 4.032

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.